Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9
The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
The bacterial CRISPR/Cas9 system allows sequence-specific gene editing in many organisms and holds promise as a tool to generate models of human diseases, for example, in human pluripotent stem cells. CRISPR/Cas9 introduces targeted double-stranded breaks (DSBs) with high efficiency, which are typically repaired by non-homologous end-joining (NHEJ) resulting in nonspecific insertions, deletions or other mutations (indels). DSBs may also be repaired by homology-directed repair (HDR) using a DNA repair template, such as an introduced single-stranded oligo DNA nucleotide (ssODN), allowing knock-in of specific mutations. Although CRISPR/Cas9 is used extensively to engineer gene knockouts through NHEJ, editing by HDR remains inefficient and can be corrupted by additional indels, preventing its widespread use for modelling genetic disorders through introducing disease-associated mutations. Furthermore, targeted mutational knock-in at single alleles to model diseases caused by heterozygous mutations has not been reported. Here we describe a CRISPR/Cas9-based genome-editing framework that allows selective introduction of mono- and bi-allelic sequence changes with high efficiency and accuracy. We show that HDR accuracy is increased dramatically by incorporating silent CRISPR/Cas-blocking mutations along with pathogenic mutations, and establish a method termed 'CORRECT' for scarless genome editing. By characterizing and exploiting a stereotyped inverse relationship between a mutation's incorporation rate and its distance to the DSB, we achieve predictable control of zygosity. Homozygous introduction requires a guide RNA targeting close to the intended mutation, whereas heterozygous introduction can be accomplished by distance-dependent suboptimal mutation incorporation or by use of mixed repair templates. Using this approach, we generated human induced pluripotent stem cells with heterozygous and homozygous dominant early onset Alzheimer's disease-causing mutations in amyloid precursor protein (APP(Swe)) and presenilin 1 (PSEN1(M146V)) and derived cortical neurons, which displayed genotype-dependent disease-associated phenotypes. Our findings enable efficient introduction of specific sequence changes with CRISPR/Cas9, facilitating study of human disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While exogenous DNA can be inserted at the target site through homology-directed repair (HDR) mechanism, successful insertion of exogenous DNA is relatively rare and is likely accompanied by loss of the second allele24.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [24]
In the citing paper
“Briefly, the majority of a HDR template’s homology arm sequences are not incorporated with on-target HDR integrations (Paquet et al., 2016)”
From Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies (2020) · cites this paper as Paquet et al., 2016
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
PEAR: a fast and accurate Illumina Paired-End reAd mergeR
Zhang, J., Kobert, K., Flouri, T., & Stamatakis, A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt593 · Cited by 4,497
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Goecks, J., Nekrutenko, A., Taylor, J., & The Galaxy Team (2010) · Genome Biology · doi:10.1186/gb-2010-11-8-r86 · Cited by 3,453
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
Cited by
Search-and-replace genome editing without double-strand breaks or donor DNA
Anzalone, A. V., Randolph, P. B., Davis, J. R., Sousa, A. A., Koblan, L. W., Levy, J. M., Chen, P. J., Wilson, C., Newby, G. A., Raguram, A., et al. (2019) · Nature · doi:10.1038/s41586-019-1711-4 · Cited by 4,767
Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184
“Comparison between ABE 7.10 and homology directed repair using the ‘CORRECT’ method 42 HEK293T cells grown in the absence of antibiotic were seeded on 48-well poly-D-lysine coated plates (Corning).”
InfluentialGenome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
Anzalone, A. V., Koblan, L. W., & Liu, D. R. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0561-9 · Cited by 2,237
Li, H., Yang, Y., Hong, W., Huang, M., Wu, M., & Zhao, X. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0089-y · Cited by 1,715
“In addition, through a gene editing platform based on single-stranded oligonucleotide DNA nucleotides and CRISPR/CAS-blocking mutations, Paquet et al.(131) generated human iPSCs with dominant ADcausing mutations in APP and presenilin 1 (PSEN1), both heterozygous and homozygous, leading to early disease onset; thereby,…”
BackgroundBase editing: precision chemistry on the genome and transcriptome of living cells
Rees, H. A., & Liu, D. R. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0059-1 · Cited by 1,675
Induced pluripotent stem cell technology: a decade of progress.
Shi, Y., Inoue, H., Wu, J. C., & Yamanaka, S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.245 · Cited by 1,525
The next generation of CRISPR–Cas technologies and applications
Pickar-Oliver, A., & Gersbach, C. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0131-5 · Cited by 1,459
Endogenous DNA damage as a source of genomic instability in cancer
Tubbs, A., & Nussenzweig, A. (2017) · Cell · doi:10.1016/j.cell.2017.01.002 · Cited by 1,452
Delivering CRISPR: a review of the challenges and approaches
Lino, C. A., Harper, J. C., Carney, J. P., & Timlin, J. A. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1474964 · Cited by 1,185
“cells (Paquet et al., 2016), and correct mutations that cause DMD (Ousterout et al.”
BackgroundLin, Y.-T., Seo, J., Gao, F., Feldman, H. M., Wen, H.-L., Penney, J., Cam, H. P., Gjoneska, E., Raja, W. K., Cheng, J., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.05.008 · Cited by 1,125
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
Komor, A. C., Badran, A. H., & Liu, D. R. (2017) · Cell · doi:10.1016/j.cell.2016.10.044 · Cited by 1,013
A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer’s disease
Park, J., Wetzel, I., Marriott, I., Dréau, D., D’Avanzo, C., Kim, D. Y., Tanzi, R. E., & Cho, H. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0175-4 · Cited by 644
Prime editing for precise and highly versatile genome manipulation
Chen, P. J., & Liu, D. R. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-022-00541-1 · Cited by 605
Past, present, and future of CRISPR genome editing technologies
Pacesa, M., Pelea, O., & Jinek, M. (2024) · Cell · doi:10.1016/j.cell.2024.01.042 · Cited by 609
Predictable and precise template-free CRISPR editing of pathogenic variants
Shen, M. W., Arbab, M., Hsu, J. Y., Worstell, D., Culbertson, S. J., Krabbe, O., Cassa, C. A., Liu, D. R., Gifford, D. K., & Sherwood, R. I. (2018) · Nature · doi:10.1038/s41586-018-0686-x · Cited by 569
Wang, H.-X., Li, M., Lee, C. M., Chakraborty, S., Kim, H.-W., Bao, G., & Leong, K. W. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00799 · Cited by 560
Base editing: advances and therapeutic opportunities
Porto, E. M., Komor, A. C., Slaymaker, I. M., & Yeo, G. W. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0084-6 · Cited by 476
Modeling Alzheimer’s disease with iPSC-derived brain cells
Penney, J., Ralvenius, W. T., & Tsai, L.-H. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0468-3 · Cited by 471
Gupta, R. M., Hadaya, J., Trehan, A., Zekavat, S. M., Roselli, C., Klarin, D., Emdin, C. A., Hilvering, C. R. E., Bianchi, V., Mueller, C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.049 · Cited by 450
“The only successful approach required two rounds of genomeediting: first to generate a cell linewith protospacer adjacentmotif (PAM) sites at theSNPwithHRandsecond togenerate the allelic series (Paquet et al., 2016) (Figure 4A).”
Cornerstones of CRISPR–Cas in drug discovery and therapy
Fellmann, C., Gowen, B. G., Lin, P.-C., Doudna, J. A., & Corn, J. E. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.238 · Cited by 443
Cholesterol and matrisome pathways dysregulated in astrocytes and microglia
TCW, J., Qian, L., Pipalia, N. H., Chao, M. J., Liang, S. A., Shi, Y., Jain, B. R., Bertelsen, S. E., Kapoor, M., Marcora, E., et al. (2022) · Cell · doi:10.1016/j.cell.2022.05.017 · Cited by 411
Continuous evolution of SpCas9 variants compatible with non-G PAMs
Miller, S. M., Wang, T., Randolph, P. B., Arbab, M., Shen, M. W., Huang, T. P., Matuszek, Z., Newby, G. A., Rees, H. A., & Liu, D. R. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0412-8 · Cited by 354
Kwart, D., Gregg, A., Scheckel, C., Murphy, E. A., Paquet, D., Duffield, M., Fak, J., Olsen, O., Darnell, R. B., & Tessier-Lavigne, M. (2019) · Neuron · doi:10.1016/j.neuron.2019.07.010 · Cited by 304
Self-citationA reference human induced pluripotent stem cell line for large-scale collaborative studies
Pantazis, C. B., Yang, A., Lara, E., McDonough, J. A., Blauwendraat, C., Peng, L., Oguro, H., Kanaujiya, J., Zou, J., Sebesta, D., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.11.004 · Cited by 310
Self-citationDeterminants of Base Editing Outcomes from Target Library Analysis and Machine Learning
Arbab, M., Shen, M. W., Mok, B., Wilson, C., Matuszek, Ż., Cassa, C. A., & Liu, D. R. (2020) · Cell · doi:10.1016/j.cell.2020.05.037 · Cited by 294
“(C→T, T→C, A→G, and G→A) with high ratios of desired substitutions to undesired insertions and deletions (indels) (Lin et al., 2014; Paquet et al., 2016).”
In vitro Models of Neurodegenerative Diseases
Slanzi, A., Iannoto, G., Rossi, B., Zenaro, E., & Constantin, G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00328 · Cited by 290
Tau-based therapies in neurodegeneration: opportunities and challenges
Li, C., & Götz, J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.155 · Cited by 272
Evaluation of variability in human kidney organoids
Phipson, B., Er, P. X., Combes, A. N., Forbes, T. A., Howden, S. E., Zappia, L., Yen, H.-J., Lawlor, K. T., Hale, L. J., Sun, J., et al. (2019) · Nature Methods · doi:10.1038/s41592-018-0253-2 · Cited by 253
CRISPR/Cas9-mediated gene targeting in Arabidopsis using sequential transformation
Miki, D., Zhang, W., Zeng, W., Feng, Z., & Zhu, J.-K. (2018) · Nature Communications · doi:10.1038/s41467-018-04416-0 · Cited by 243
Hematopoietic Stem Cell Gene Therapy: Progress and Lessons Learned
Morgan, R. A., Gray, D., Lomova, A., & Kohn, D. B. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.10.010 · Cited by 245
“In general, the lengths of the gene repair tracts mediated by HDR are relatively short ( 40 bp), so it may be necessary to develop a panel of nuclease/donor template combinations capable of performing efficient editing to cover an entire gene region (Paquet et al., 2016).”
BackgroundGuttikonda, S. R., Sikkema, L., Tchieu, J., Saurat, N., Walsh, R. M., Harschnitz, O., Ciceri, G., Sneeboer, M., Mazutis, L., Setty, M., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00796-z · Cited by 243
Prime editing for functional repair in patient-derived disease models
Schene, I. F., Joore, I. P., Oka, R., Mokry, M., van Vugt, A. H. M., van Boxtel, R., van der Doef, H. P. J., van der Laan, L. J. W., Verstegen, M. M. A., van Hasselt, P. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19136-7 · Cited by 237
Precision genome editing using synthesis-dependent repair of Cas9-induced DNA breaks
Paix, A., Folkmann, A., Goldman, D. H., Kulaga, H., Grzelak, M. J., Rasoloson, D., Paidemarry, S., Green, R., Reed, R. R., & Seydoux, G. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711979114 · Cited by 235
“Editing efficiency has been observed to decrease with increasing distance between the edit and the DSB (6).”
BackgroundGhatak, S., Dolatabadi, N., Trudler, D., Zhang, X., Wu, Y., Mohata, M., Ambasudhan, R., Talantova, M., & Lipton, S. A. (2019) · eLife · doi:10.7554/elife.50333 · Cited by 227
“For example, recent studies have shown increased calcium transients in a cerebral organotypic hiPSC-derived culture system bearing FAD mutations (Park et al., 2018).”
BackgroundIn vivo base editing of post-mitotic sensory cells
Yeh, W.-H., Chiang, H., Rees, H. A., Edge, A. S. B., & Liu, D. R. (2018) · Nature Communications · doi:10.1038/s41467-018-04580-3 · Cited by 225
Synergistic effects of common schizophrenia risk variants
Schrode, N., Ho, S.-M., Yamamuro, K., Dobbyn, A., Huckins, L., Matos, M. R., Cheng, E., Deans, P. J. M., Flaherty, E., Barretto, N., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0497-5 · Cited by 234
Loss-of-function genetic tools for animal models: cross-species and cross-platform differences
Housden, B. E., Muhar, M., Gemberling, M., Gersbach, C. A., Stainier, D. Y. R., Seydoux, G., Mohr, S. E., Zuber, J., & Perrimon, N. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2016.118 · Cited by 220
Nishiyama, J., Mikuni, T., & Yasuda, R. (2017) · Neuron · doi:10.1016/j.neuron.2017.10.004 · Cited by 215
CRISPR off-target analysis in genetically engineered rats and mice
Anderson, K. R., Haeussler, M., Watanabe, C., Janakiraman, V., Lund, J., Modrusan, Z., Stinson, J., Bei, Q., Buechler, A., Yu, C., et al. (2018) · Nature Methods · doi:10.1038/s41592-018-0011-5 · Cited by 216
Zuo, E., Cai, Y.-J., Li, K., Wei, Y., Wang, B.-A., Sun, Y., Liu, Z., Liu, J., Hu, X., Wei, W., et al. (2017) · Cell Research · doi:10.1038/cr.2017.81 · Cited by 209
Easy quantification of template-directed CRISPR/Cas9 editing
Brinkman, E. K., Kousholt, A. N., Harmsen, T., Leemans, C., Chen, T., Jonkers, J., & van Steensel, B. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky164 · Cited by 201
“However, it has been reported that the frequency of such double templated / non-templated mutations is low when a PAM disrupting mutation is included (24,25).”
Liu, Y., Zou, R. S., He, S., Nihongaki, Y., Li, X., Razavi, S., Wu, B., & Ha, T. (2020) · Science · doi:10.1126/science.aay8204 · Cited by 196
CRISPR-Cas Tools and Their Application in Genetic Engineering of Human Stem Cells and Organoids
Hendriks, D., Clevers, H., & Artegiani, B. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.10.014 · Cited by 192
Shou, J., Li, J., Liu, Y., & Wu, Q. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.06.021 · Cited by 191
Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies
Roth, T. L., Li, P. J., Blaeschke, F., Nies, J. F., Apathy, R., Mowery, C., Yu, R., Nguyen, M. L. T., Lee, Y., Truong, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.03.039 · Cited by 186
Development of CRISPR-Cas systems for genome editing and beyond
Zhang, F. (2019) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583519000052 · Cited by 181
“…the efficiency of gene insertion either through homologous recombination or independent pathways are continuing to be developed (Maruyama et al., 2015; Paquet et al., 2016; Richardson et al., 2016, 2018; Schmid-Burgk et al., 2016; Suzuki et al., 2016; Kan et al., 2017; Canny et al., 2018).”
BackgroundPrecision genome editing in the CRISPR era
Salsman, J., & Dellaire, G. (2017) · Biochemistry and Cell Biology · doi:10.1139/bcb-2016-0137 · Cited by 185
CRISPR-Cas9-mediated homology-directed repair for precise gene editing
Liao, H., Wu, J., VanDusen, N. J., Li, Y., & Zheng, Y. (2024) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2024.102344 · Cited by 164
Precision genome editing using cytosine and adenine base editors in mammalian cells
Huang, T. P., Newby, G. A., & Liu, D. R. (2021) · Nature Protocols · doi:10.1038/s41596-020-00450-9 · Cited by 175
A catalogue of biochemically diverse CRISPR-Cas9 orthologs
Gasiunas, G., Young, J. K., Karvelis, T., Kazlauskas, D., Urbaitis, T., Jasnauskaite, M., Grusyte, M. M., Paulraj, S., Wang, P.-H., Hou, Z., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19344-1 · Cited by 177
Carlson-Stevermer, J., Abdeen, A. A., Kohlenberg, L., Goedland, M., Molugu, K., Lou, M., & Saha, K. (2017) · Nature Communications · doi:10.1038/s41467-017-01875-9 · Cited by 170
Saturation variant interpretation using CRISPR prime editing
Erwood, S., Bily, T. M. I., Lequyer, J., Yan, J., Gulati, N., Brewer, R. A., Zhou, L., Pelletier, L., Ivakine, E. A., & Cohn, R. D. (2022) · Nature Biotechnology · doi:10.1038/s41587-021-01201-1 · Cited by 163
Unbiased investigation of specificities of prime editing systems in human cells
Kim, D. Y., Moon, S. B., Ko, J., Kim, Y.-S., & Kim, D. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa764 · Cited by 165
“Precise genome editing is achievable by HDR in the presence of designed donor DNAs (6–10), but HDR efficiency still remains unsatisfactory (11,12).”
BackgroundA novel fluorescence biosensor based on CRISPR/Cas12a integrated MXenes for detecting Aflatoxin B1
Wu, Z., Sun, D., Pu, H., & Wei, Q. (2022) · Talanta · doi:10.1016/j.talanta.2022.123773 · Cited by 150
Park, S. H., Lee, C. M., Dever, D. P., Davis, T., Camarena, J., Srifa, W., Zhang, Y., Paikari, A., Chang, A. K., Porteus, M. H., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz475 · Cited by 163
“R-66 gRNA thus may facilitate an increased level of gene correction using a short ssODN template (41,44).”
BackgroundCRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics
Bhardwaj, S., Kesari, K. K., Rachamalla, M., Mani, S., Ashraf, G. M., Jha, S. K., Kumar, P., Ambasta, R. K., Dureja, H., Devkota, H. P., et al. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.07.001 · Cited by 158
Ma, N., Zhang, J. Z., Itzhaki, I., Zhang, S., Chen, H., Haddad, F., Kitani, T., Wilson, K. D., Tian, L., Shrestha, R., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.032273 · Cited by 145
Neuronal apolipoprotein E4 increases cell death and phosphorylated tau release in alzheimer disease
Wadhwani, A. R., Affaneh, A., Van Gulden, S., & Kessler, J. A. (2019) · Annals of Neurology · doi:10.1002/ana.25455 · Cited by 142
Zebrafish: A Resourceful Vertebrate Model to Investigate Skeletal Disorders
Tonelli, F., Bek, J. W., Besio, R., Clercq, A. D., Leoni, L., Salmon, P., Coucke, P. J., Willaert, A., & Forlino, A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00489 · Cited by 168
Application of stem cells in regeneration medicine
Jin, Y. H., Li, S., Yu, Q., Chen, T., & Liu, D. (2023) · MedComm · doi:10.1002/mco2.291 · Cited by 165
Drug screening for human genetic diseases using iPSC models
Elitt, M. S., Barbar, L., & Tesar, P. J. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy186 · Cited by 153
Genome Engineering in Rice Using Cas9 Variants that Recognize NG PAM Sequences
Hua, K., Tao, X., Han, P., Wang, R., & Zhu, J. (2019) · Molecular Plant · doi:10.1016/j.molp.2019.03.009 · Cited by 151
Stem Cells, Genome Editing, and the Path to Translational Medicine
Soldner, F., & Jaenisch, R. (2018) · Cell · doi:10.1016/j.cell.2018.09.010 · Cited by 151
“Examples include Parkinson’s and Alzheimer’s disease (Paquet et al., 2016; Reinhardt et al., 2013; Schöndorf et al., 2014), hereditary motor and sensory neuropathy (Murakami et al.”
van Agtmaal, E. L., André, L. M., Willemse, M. P., Cumming, S. A., van Kessel, I. D. G., van den Broek, W. J. A. A., Gourdon, G., Furling, D., Mouly, V., Monckton, D. G., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.10.014 · Cited by 152
“Insertional recombination of this donor fragment by HDR would leave no or only minor sequence alterations around the CRISPR-2 and -3 recognition sites.(58) Genome editing with this two-step approach is, however, only realistic for use in cells in vitro and too elaborate for use in vivo.”
Advances in CRISPR/Cas-based Gene Therapy in Human Genetic Diseases
Wu, S., Li, Q.-C., Yin, C., Xue, W., & Song, C. (2020) · Theranostics · doi:10.7150/thno.43360 · Cited by 157
“…cell line NHEJ-mediated gene deletion Raas et al, 2019, (34) Alzheimer’s disease APPS & PSEN1M1 Human and Mouse IPS Cell line HDR-mediated mutation Paquet et al, 2016, (35) Duchenne muscular dystrophy (DMD) DMD Mouse NHEJ-mediated exon removal Egorova et al, 2019, (36) Atherosclerosis LDLR Mouse…”
BackgroundHow iPS cells changed the world
Scudellari, M. (2016) · Nature · doi:10.1038/534310a · Cited by 142
Generation and validation of homozygous fluorescent knock-in cells using CRISPR-Cas9 genome editing
Koch, B., Nijmeijer, B., Kueblbeck, M., Cai, Y., Walther, N., & Ellenberg, J. (2018) · Nature Protocols · doi:10.1038/nprot.2018.042 · Cited by 134
Genome editing: A perspective on the application of CRISPR/Cas9 to study human diseases (Review)
Rodríguez-Rodríguez, D. R., Ram�rez‐Sol�s, R., Garza‐Elizondo, M. A., Garza‐Rodr�guez, M., & Barrera-Saldaña, H. A. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4112 · Cited by 199
“amyloidosis), its expression could be down regulated at several points in its pathway of expression (96).”
Background3D culture models of Alzheimer’s disease: a road map to a “cure-in-a-dish”
Choi, S. H., Kim, Y. H., Quinti, L., Tanzi, R. E., & Kim, D. Y. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0139-7 · Cited by 132
“As predicted, APP knock-in neurons showed increase in total Aβ levels, while the neurons with PSEN1 showed ~2 fold increases in Aβ42/Aβ40 ratio [56].”
BackgroundMethodDetection of Deleterious On-Target Effects after HDR-Mediated CRISPR Editing
Weisheit, I., Kroeger, J. A., Malik, R., Klimmt, J., Crusius, D., Dannert, A., Dichgans, M., & Paquet, D. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107689 · Cited by 125
Self-citationPrecise Editing at DNA Replication Forks Enables Multiplex Genome Engineering in Eukaryotes
Barbieri, E. M., Muir, P., Akhuetie‐Oni, B. O., Yellman, C. M., & Isaacs, F. J. (2017) · Cell · doi:10.1016/j.cell.2017.10.034 · Cited by 131
Highly efficient genome editing for single-base substitutions using optimized ssODNs with Cas9-RNPs
Okamoto, S., Amaishi, Y., Maki, I., Enoki, T., & Mineno, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-41121-4 · Cited by 148
Development of hRad51–Cas9 nickase fusions that mediate HDR without double-stranded breaks
Rees, H. A., Yeh, W.-H., & Liu, D. R. (2019) · Nature Communications · doi:10.1038/s41467-019-09983-4 · Cited by 138
Optimized design parameters for CRISPR Cas9 and Cas12a homology-directed repair
Schubert, M. S., Thommandru, B., Woodley, J., Turk, R., Yan, S., Kurgan, G., McNeill, M., & Rettig, G. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-98965-y · Cited by 148
CRISPR/Cas9-Mediated Multi-Allelic Gene Targeting in Sugarcane Confers Herbicide Tolerance
Öz, M. T., Altpeter, A., Karan, R., Merotto, A., & Altpeter, F. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.673566 · Cited by 141
“Homology-directed repair repair frequencies are typically negatively correlated with distance to the DSB site (Baur et al., 1990; Paquet et al., 2016).”
BackgroundLafaille, F. G., Harschnitz, O., Lee, Y. S., Zhang, P., Hasek, M. L., Kerner, G., Itan, Y., Ewaleifoh, O., Rapaport, F., Carlile, T. M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0672-3 · Cited by 128
Self-citationNelson, M. R., Liu, P., Agrawal, A., Yip, O., Blumenfeld, J., Traglia, M., Kim, M. J., Koutsodendris, N., Rao, A., Grone, B., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01480-8 · Cited by 120
“To generate isogenic E4-S/S and E4-R/S hiPSC lines, CRISPR–Cas9 editing strategy was used 75 . sgRNAs were designed using CRISPOR to optimize for distance of cut site to mutation, high targeting efficiency and minimal predicted off-target sites 70,76 .”
MethodCRISPR/Cas9 editing of APP C-terminus attenuates β-cleavage and promotes α-cleavage
Sun, J., Carlson-Stevermer, J., Das, U., Shen, M., Delenclos, M., Snead, A. M., Koo, S. Y., Wang, L., Qiao, D., Loi, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07971-8 · Cited by 112
Self-citationIn vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells
Martínez-Lage, M., Torres-Ruiz, R., Puig-Serra, P., Moreno-Gaona, P., Martín, M. C., Moya, F., Bustamante, O. Q., García-Silva, S., Carcaboso, A. M., Petazzi, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18875-x · Cited by 128
Present and future prospects for wheat improvement through genome editing and advanced technologies
Li, S., Zhang, C., Li, J., Yan, L., Wang, N., & Xia, L. (2021) · Plant Communications · doi:10.1016/j.xplc.2021.100211 · Cited by 129
“, 2011), whereas SDSA has been proposed as the primary repair mechanism upon the availability of a DRT in CRISPR/Cas-mediated HDR (Paquet et al., 2016; Richardson et al., 2016; Kan et al., 2017; Li et al., 2018a, 2020i).”
BackgroundInfluentialGenome editing by natural and engineered CRISPR-associated nucleases
Wu, W. Y., Lebbink, J. H. G., Kanaar, R., Geijsen, N., & John van der, O. O. S. T. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0080-x · Cited by 124
Precise and efficient scarless genome editing in stem cells using CORRECT
Kwart, D., Paquet, D., Teo, S., & Tessier‐Lavigne, M. (2017) · Nature Protocols · doi:10.1038/nprot.2016.171 · Cited by 128
Self-citationLee, A., Kondapalli, C., Virga, D. M., Lewis, T. L., Koo, S. Y., Ashok, A., Mairet‐Coello, G., Herzig, S., Foretz, M., Viollet, B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32130-5 · Cited by 128
Self-citationLessard, S., Francioli, L. C., Alföldi, J., Tardif, J., Ellinor, P. T., MacArthur, D. G., Lettre, G., Orkin, S. H., & Canver, M. C. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714640114 · Cited by 122
“that HDR efficiency decreases as a function of the distance between the variant and the double-strand break site (22).”
BackgroundHuman Neurospheroid Arrays for In Vitro Studies of Alzheimer’s Disease
Jorfi, M., D’Avanzo, C., Tanzi, R. E., Kim, D. Y., & Irimia, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-20436-8 · Cited by 120
RIPK1 can mediate apoptosis in addition to necroptosis during embryonic development
Zhang, X., Dowling, J. P., & Zhang, J. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1490-8 · Cited by 122
Image-based high-content screening in drug discovery
Lin, S., Schorpp, K., Rothenaigner, I., & Hadian, K. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.06.001 · Cited by 124
Editing the genome of hiPSC with CRISPR/Cas9: disease models
Bassett, A. R. (2017) · Mammalian Genome · doi:10.1007/s00335-017-9684-9 · Cited by 109
TLR3 controls constitutive IFN-β antiviral immunity in human fibroblasts and cortical neurons
Gao, D., Ciancanelli, M. J., Zhang, P., Harschnitz, O., Bondet, V., Hasek, M. L., Chen, J., Mu, X. N., Itan, Y., Cobat, A., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci134529 · Cited by 124
Gou, L., Lim, D., Ma, W., Aubol, B. E., Hao, Y., Wang, X., Zhao, J., Liang, Z., Shao, C., Zhang, X., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.020 · Cited by 126
“P1S9A/+, P1S43A/+, and P1S9S43A/+ knock-in mice were generated by using a CRISPR/Cas9-mediated genome editing approach (Paquet et al., 2016).”
MethodEnhanced Cas12a editing in mammalian cells and zebrafish
Liu, P., Luk, K., Shin, M., Idrizi, F., Kwok, S., Roscoe, B., Mintzer, E., Suresh, S., Morrison, K., Frazão, J. B., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz184 · Cited by 109
“Given that FnoCas12a can potentially target more than four times as many sequences within the zebrafish genome, this nuclease could be particularly useful for the targeted knock in of DNA sequences, since the efficiency of knock-in is a function of the proximity of the nuclease target site to the desired sequence alte…”
BackgroundHigh-Throughput Imaging for the Discovery of Cellular Mechanisms of Disease
Pegoraro, G., & Misteli, T. (2017) · Trends in Genetics · doi:10.1016/j.tig.2017.06.005 · Cited by 113
“The capacity to model monogenic diseases using iPS cells will be greatly expanded by genome editing with RNA-guided nucleases such as the CRISPR/Cas9 system, which allows the specific introduction of pathogenic mutations in wild-type iPS cells [70], or their correction in patient-derived iPS cells [71,72].”
BackgroundSuzuki, Y., Onuma, H., Sato, R., Sato, Y., Hashiba, A., Maeki, M., Tokeshi, M., Kayesh, M. E. H., Kohara, M., Tsukiyama–Kohara, K., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.12.013 · Cited by 107
Barák, M., Fedorová, V., Pospíšilová, V., Raška, J., Vochyánová, S., Sedmík, J., Hříbková, H., Klímová, H., Váňová, T., & Bohačiaková, D. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10254-3 · Cited by 107
“In general, fAD neurons displayed a high Aβ42/Aβ40 ratio [73, 170, 172, 192, 193, 197].”
BackgroundCRISPR–Cas9 System for Genome Engineering of Photosynthetic Microalgae
Patel, V., Soni, N., Prasad, V., Sapre, A. V., Dasgupta, S., & Bhadra, B. (2019) · Molecular Biotechnology · doi:10.1007/s12033-019-00185-3 · Cited by 104
Functional variomics and network perturbation: connecting genotype to phenotype in cancer
Yi, S. S., Lin, S., Li, Y., Zhao, W., Mills, G. B., & Sahni, N. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.8 · Cited by 114
Functional Genomics via CRISPR–Cas
Ford, K. M., McDonald, D., & Mali, P. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.06.034 · Cited by 106
Hit and go CAS9 delivered through a lentiviral based self-limiting circuit
Petris, G., Casini, A., Montagna, C., Lorenzin, F., Prandi, D., Romanel, A., Zasso, J., Conti, L., Demichelis, F., & Cereseto, A. (2017) · Nature Communications · doi:10.1038/ncomms15334 · Cited by 98
Programmed genome editing of the omega-1 ribonuclease of the blood fluke, Schistosoma mansoni
Ittiprasert, W., Mann, V. H., Karinshak, S. E., Coghlan, A., Rinaldi, G., Sankaranarayanan, G., Chaidee, A., Tanno, T., Kumkhaek, C., Prangtaworn, P., et al. (2019) · eLife · doi:10.7554/elife.41337 · Cited by 116
“The chromosomal lesion was repaired by the non-homologous end joining 287 (NHEJ) pathway (64) in the absence of a donor oligonucleotide and by homology directed repair 288 (HDR) when a single stranded oligonucleotide donor template was provided (65-67).”
BackgroundBoel, A., Saffel, H. D., Steyaert, W., Callewaert, B. L., Paepe, A. D., Coucke, P. J., & Willaert, A. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.035352 · Cited by 104
“Moreover, these perfect repair rates drop even further if the distance between the base alteration and the Cas9 cut site increases, a phenomenon that was observed previously (Elliott et al., 1998; Paquet et al., 2016; Ran et al., 2013b).”
Metadata
- Authors
- Paquet, D., Kwart, D., Chen, A., Sproul, A., Jacob, S., Teo, S., Olsen, K. M., Gregg, A., Noggle, S., & Tessier-Lavigne, M.
- Affiliations
- Rockefeller University (US)
- New York Stem Cell Foundation (US)
- Cornell University (US)
- Venue
- Nature
- Published
- 2016-04-27
- Volume
- 533
- Issue
- 7601
- Pages
- 125-129
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2343876552
- Cited by
- 951
- References
- 49
- Citations by year
- 2026: 58 · 2025: 56 · 2024: 90 · 2023: 87 · 2022: 104 · 2021: 106 · 2020: 125 · 2019: 93 · 2018: 111 · 2017: 91 · 2016: 29
- FWCI
- 56.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (UL1TR000043)
- National Institute of General Medical Sciences (T32GM007739)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- CRISPR/Cas9, homology-directed repair, non-homologous end joining, amyloid precursor protein, presenilin 1, early-onset Alzheimer's disease, induced pluripotent stem cells, disease modeling
- MeSH terms
- RNA, Guide, CRISPR-Cas Systems, Adolescent, Alleles, Alzheimer Disease, Animals, Base Sequence, DNA Repair, Female, Genes, Dominant, Genetic Engineering, Heterozygote, Homozygote, Humans, Male, Mutation, Substrate Specificity, Templates, Genetic, Mutagenesis, Amyloid beta-Protein Precursor, Sequence Homology, Age of Onset, Mice, Presenilins, DNA Cleavage, DNA Breaks, Double-Stranded, Genetic Association Studies, Induced Pluripotent Stem Cells, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.